Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder

0
48

  • 1.

    Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V) (American Psychiatric Association, Washington, DC, 2013).

  • 2.

    Barbaresi, W. J. et al. Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics 131, 637–644. https://doi.org/10.1542/peds.2012-2354 (2013).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 3.

    Biederman, J., Petty, C. R., Clarke, A., Lomedico, A. & Faraone, S. V. Predictors of persistent ADHD: an 11-year follow-up study. J. Psychiatr. Res. 45, 150–155. https://doi.org/10.1016/j.jpsychires.2010.06.009 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • 4.

    Cheung, C. H. M. et al. Childhood predictors of adolescent and young adult outcome in ADHD. J. Psychiatr. Res. 62, 92–100. https://doi.org/10.1016/j.jpsychires.2015.01.011 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 5.

    Lara, C. et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol. Psychiatry 65, 46–54. https://doi.org/10.1016/j.biopsych.2008.10.005 (2009).

    Article 
    PubMed 

    Google Scholar
     

  • 6.

    Harpin, V. A. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch. Dis. Child. 90(Suppl 1), i2-7. https://doi.org/10.1136/adc.2004.059006 (2005).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 7.

    Hoza, B. et al. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder?. J. Consult. Clin. Psychol. 73, 411–423. https://doi.org/10.1037/0022-006x.73.3.411 (2005).

    Article 
    PubMed 

    Google Scholar
     

  • 8.

    Saito, M. Japanese Guideline for Diagnosis and Treatment of AD/HD 4th edn. (Jiho, Tokyo, 2016) (in Japanese).


    Google Scholar
     

  • 9.

    Miyachi, T. et al. The investigation into the actual conditions of medication for the child with attention deficit/hyperactivity disorder (AD/HD) in Japan. Psychiatr. Neurolo. Paediatr. Jpn. 50, 419–427 (2010) (in Japanese).


    Google Scholar
     

  • 10.

    Kimura, S., Sato, T., Ikeda, S., Noda, M. & Nakayama, T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J. Epidemiol. 20, 413–419. https://doi.org/10.2188/jea.je20090066 (2010).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 11.

    Barner, J. C., Khoza, S. & Oladapo, A. ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Curr. Med. Res. Opin. 27(Suppl 2), 13–22. https://doi.org/10.1185/03007995.2011.603303 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • 12.

    Brinkman, W. B., Sucharew, H., Majcher, J. H. & Epstein, J. N. Predictors of medication continuity in children with ADHD. Pediatrics 141, e20172580. https://doi.org/10.1542/peds.2017-2580 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 13.

    Faraone, S. V., Biederman, J. & Zimmerman, B. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD. J. Atten. Disord. 11, 157–166. https://doi.org/10.1177/1087054706295663 (2007).

    Article 
    PubMed 

    Google Scholar
     

  • 14.

    Gau, S.S.-F. et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J. Clin. Psychiatry 69, 131–140. https://doi.org/10.4088/jcp.v69n0118 (2008).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 15.

    Sanchez, R. J., Crismon, M. L., Barner, J. C., Bettinger, T. & Wilson, J. P. Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy 25, 909–917. https://doi.org/10.1592/phco.2005.25.7.909 (2005).

    Article 
    PubMed 

    Google Scholar
     

  • 16.

    Thiruchelvam, D., Charach, A. & Schachar, R. J. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 40, 922–928. https://doi.org/10.1097/00004583-200108000-00014 (2001).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 17.

    Marcus, S. C., Wan, G. J., Kemner, J. E. & Olfson, M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch. Pediatr. Adolesc. Med. 159, 572–578. https://doi.org/10.1001/archpedi.159.6.572 (2005).

    Article 
    PubMed 

    Google Scholar
     

  • 18.

    Visser, S. N., Lesesne, C. A. & Perou, R. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder. Pediatrics 119(Suppl 1), S99-106. https://doi.org/10.1542/peds.2006-2089O (2007).

    Article 
    PubMed 

    Google Scholar
     

  • 19.

    Storebø, O. J. et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents—assessment of adverse events in non-randomised studies. Cochrane Database Syst. Rev. 5, CD012069. https://doi.org/10.1002/14651858.CD012069.pub2 (2018).

    Article 
    PubMed 

    Google Scholar
     

  • 20.

    Swanson, J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs 17, 117–131. https://doi.org/10.2165/00023210-200317020-00004 (2003).

    Article 
    PubMed 

    Google Scholar
     

  • 21.

    Pharmaceuticals and Medical Devices Agency. https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/800155_1179009G1022_1_17. Accessed Jan 2021.

  • 22.

    Statistics_Bureau_of_Japan. Japanese Population on the First Day of Every Month. https://www.stat.go.jp/data/jinsui/2.html#monthly. Accessed Jan 2021.

  • 23.

    Ching, C., Eslick, G. D. & Poulton, A. S. Evaluation of methylphenidate safety and maximum-dose titration rationale in attention-deficit/hyperactivity disorder: a meta-analysis. JAMA Pediatr. 173, 630–639. https://doi.org/10.1001/jamapediatrics.2019.0905 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 24.

    Razani, N. et al. Neighborhood characteristics and ADHD: results of a national study. J. Atten. Disord. 19, 731–740. https://doi.org/10.1177/1087054714542002 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • 25.

    Lash, T. L. Applying Quantitative Bias Analysis to Epidemiologic Data (Springer, Berlin, 2009).


    Google Scholar
     

  • 26.

    Bachmann, C. J. et al. Trends in ADHD medication use in children and adolescents in five western countries, 2005–2012. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 27, 484–493. https://doi.org/10.1016/j.euroneuro.2017.03.002 (2017).

    CAS 
    Article 

    Google Scholar
     

  • 27.

    McCarthy, S. et al. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr. 12, 78. https://doi.org/10.1186/1471-2431-12-78 (2012).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 28.

    Stephenson, C. P., Karanges, E. & McGregor, I. S. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust. N. Zeal. J. Psychiatry 47, 74–87. https://doi.org/10.1177/0004867412466595 (2013).

    Article 

    Google Scholar
     

  • 29.

    Zuvekas, S. H. & Vitiello, B. Stimulant medication use in children: a 12-year perspective. Am. J. Psychiatry 169, 160–166. https://doi.org/10.1176/appi.ajp.2011.11030387 (2012).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 30.

    Okumura, Y. et al. Prevalence, incidence and persistence of ADHD drug use in Japan. Epidemiol. Psychiatr. Sci. 28, 692–696. https://doi.org/10.1017/s2045796018000252 (2019).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 31.

    Burcu, M., Zito, J. M., Metcalfe, L., Underwood, H. & Safer, D. J. Trends in stimulant medication use in commercially insured youths and adults, 2010–2014. JAMA Psychiatry 73, 992–993. https://doi.org/10.1001/jamapsychiatry.2016.1182 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • 32.

    Karlstad, Ø., Furu, K., Stoltenberg, C., Håberg, S. E. & Bakken, I. J. ADHD treatment and diagnosis in relation to children’s birth month: Nationwide cohort study from Norway. Scand. J. Public Health 45, 343–349. https://doi.org/10.1177/1403494817708080 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • 33.

    Beau-Lejdstrom, R., Douglas, I., Evans, S. J. W. & Smeeth, L. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. BMJ Open 6, e010508. https://doi.org/10.1136/bmjopen-2015-010508 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 34.

    Kovess, V. et al. Psychotropic medication use in French children and adolescents. J. Child Adolesc. Psychopharmacol. 25, 168–175. https://doi.org/10.1089/cap.2014.0058 (2015).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 35.

    Piovani, D., Clavenna, A., Cartabia, M. & Bonati, M. Psychotropic medicine prescriptions in Italian youths: a multiregional study. Eur. Child Adolesc. Psychiatry 25, 235–245. https://doi.org/10.1007/s00787-015-0726-0 (2016).

    Article 
    PubMed 

    Google Scholar
     

  • 36.

    Bachmann, C. J., Philipsen, A. & Hoffmann, F. ADHD in Germany: trends in diagnosis and pharmacotherapy. Dtsch. Arztebl. Int. 114, 141–148. https://doi.org/10.3238/arztebl.2017.0141 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • 37.

    Bolea-Alamañac, B. et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. (Oxford) 28, 179–203. https://doi.org/10.1177/0269881113519509 (2014).

    Article 

    Google Scholar
     

  • 38.

    Kooij, S. J. J. et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 10, 67. https://doi.org/10.1186/1471-244x-10-67 (2010).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 39.

    National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. https://www.nice.org.uk/guidance/ng87 (2019).

  • 40.

    Cortese, S. et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 5, 727–738. https://doi.org/10.1016/s2215-0366(18)30269-4 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 41.

    Liu, Q., Zhang, H., Fang, Q. & Qin, L. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: meta-analysis based on head-to-head trials. J. Clin. Exp. Neuropsychol. 39, 854–865. https://doi.org/10.1080/13803395.2016.1273320 (2017).

    Article 
    PubMed 

    Google Scholar
     

  • 42.

    Howland, R. H. Medication holidays. J. Psychosoc. Nurs. Ment. Health Serv. 47, 15–18. https://doi.org/10.3928/02793695-20090804-01 (2009).

    Article 
    PubMed 

    Google Scholar
     

  • 43.

    Hodgkins, P., Sasane, R., Christensen, L., Harley, C. & Liu, F. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population. Curr. Med. Res. Opin. 27(Suppl 2), 53–62. https://doi.org/10.1185/03007995.2011.623158 (2011).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 44.

    Lachaine, J., Beauchemin, C., Sasane, R. & Hodgkins, P. S. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective. Postgrad. Med. 124, 139–148. https://doi.org/10.3810/pgm.2012.05.2557 (2012).

    Article 
    PubMed 

    Google Scholar
     

  • 45.

    Marcus, S. C. & Durkin, M. Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 50, 480–489. https://doi.org/10.1016/j.jaac.2011.02.007 (2011).

    Article 
    PubMed 

    Google Scholar
     

  • 46.

    Rucklidge, J. J. Gender differences in attention-deficit/hyperactivity disorder. Psychiatr. Clin. N. Am. 33, 357–373. https://doi.org/10.1016/j.psc.2010.01.006 (2010).

    Article 

    Google Scholar
     

  • 47.

    Cornforth, C., Sonuga-Barke, E. & Coghill, D. Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients. Curr. Pharm. Des. 16, 2424–2433. https://doi.org/10.2174/138161210791959827 (2010).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 48.

    Katzman, M. A. & Sternat, T. A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder. CNS Drugs 28, 1005–1033. https://doi.org/10.1007/s40263-014-0175-1 (2014).

    CAS 
    Article 
    PubMed 

    Google Scholar
     

  • 49.

    Storebø, O. J. et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ 351, h5203. https://doi.org/10.1136/bmj.h5203 (2015).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 50.

    Treuer, T. et al. A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability. J. Child Adolesc. Psychopharmacol. 23, 179–193. https://doi.org/10.1089/cap.2012.0093 (2013).

    CAS 
    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 51.

    Hvolby, A. Associations of sleep disturbance with ADHD: implications for treatment. Atten. Defic. Hyperact. Disord. 7, 1–18. https://doi.org/10.1007/s12402-014-0151-0 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • 52.

    Martins, R. et al. Sleep disturbance in children with attention-deficit hyperactivity disorder: a systematic review. Sleep Sci. 12, 295–301. https://doi.org/10.5935/1984-0063.20190088 (2019).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 53.

    Wajszilber, D., Santiseban, J. A. & Gruber, R. Sleep disorders in patients with ADHD: impact and management challenges. Nat. Sci. Sleep 10, 453–480. https://doi.org/10.2147/nss.S163074 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • 54.

    Corkum, P. et al. The effects of extended-release stimulant medication on sleep in children with ADHD. J. Can. Acad. Child Adolesc. Psychiatry 29, 33–43 (2020).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 55.

    Kidwell, K. M., Van Dyk, T. R., Lundahl, A. & Nelson, T. D. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics 136, 1144–1153. https://doi.org/10.1542/peds.2015-1708 (2015).

    Article 
    PubMed 

    Google Scholar
     

  • Source link

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here